I
CORT icon

InceptionR’s Corcept Therapeutics CORT Stock Holding History

InceptionR’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,612
Closed -$347K – 688
2026
Q1 		$347K Buy
+8,612
New +$322K 0.08% 438
2025
Q1 		– Sell
-10,431
Closed -$526K – 594
2024
Q4 		$526K Buy
10,431
+2,991
+40% +$157K 0.12% 317
2024
Q3 		$344K Buy
+7,440
New +$264K 0.08% 419

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's CORT Position: Q2 2026 in Review

InceptionR sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 8,612 shares — an estimated $347K sold.

InceptionR first reported a position in CORT in Q3 2024 and held it in 3 quarters. The position peaked at $526K in Q4 2024. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • InceptionR reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
  • InceptionR sold 8,612 Corcept Therapeutics shares in Q2 2026, an estimated $347K.
  • InceptionR first reported a position in Corcept Therapeutics in Q3 2024 and held it in 3 quarters.
  • InceptionR's Corcept Therapeutics position peaked at $526K in Q4 2024.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.